No relapse of neuromyelitis optica during drug-induced B-lymphopenia with hypogammaglobulinemia

Neurology. 2010 Nov 9;75(19):1745-7. doi: 10.1212/WNL.0b013e3181fc2788.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Agammaglobulinemia / chemically induced
  • Agammaglobulinemia / diagnosis
  • Agammaglobulinemia / immunology*
  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Aquaporin 4 / immunology
  • Autoantibodies / biosynthesis
  • B-Lymphocytes* / drug effects
  • B-Lymphocytes* / immunology
  • B-Lymphocytes* / pathology
  • Female
  • Humans
  • Lymphopenia / chemically induced*
  • Lymphopenia / diagnosis*
  • Lymphopenia / pathology
  • Neuromyelitis Optica / diagnosis
  • Neuromyelitis Optica / immunology
  • Neuromyelitis Optica / prevention & control*
  • Rituximab
  • Secondary Prevention

Substances

  • AQP4 protein, human
  • Antibodies, Monoclonal, Murine-Derived
  • Aquaporin 4
  • Autoantibodies
  • Rituximab